Sign In
Buy AGNPF
$0.248
-0.0513 (-17.12%)
At Close: Jul 31, 2026
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
07:00am, Monday, 17'th Nov 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Al
Algernon Health strikes US neuroimaging deal with AMI, closes first tranche of private placement
03:55am, Monday, 17'th Nov 2025
Algernon Health (CSE:AGN, OTCQB:AGNPF) said on Monday it has signed a strategic business and investment agreement with US-based American Molecular Imaging...
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
07:55pm, Friday, 14'th Nov 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “
Algernon Health announces private placement to support Alzheimer's program
08:33am, Thursday, 06'th Nov 2025
Algernon Health (CSE:AGN, OTCQB:AGNPF) announced that it plans to raise up to $500,000 through a non-brokered private placement of units priced at $0.07 each. The proceeds from the financing will be u
Algernon Health Announces Private Placement
07:04am, Thursday, 06'th Nov 2025
VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is
Algernon Health bets on the brain: Inside its move into Alzheimer's diagnostics
09:30am, Monday, 03'rd Nov 2025
Christopher Moreau isn't shy about his ambitions. The CEO of Algernon Health (CSE:AGN, OTCQB:AGNPF) wants to build a network of neuroimaging centers across North America, clinics that could help detec
CSE Bulletin: Name Change - Algernon Pharmaceuticals Inc. (AGN)
02:19pm, Thursday, 16'th Oct 2025
Toronto, Ontario--(Newsfile Corp. - Le 16 octobre/October 2025) - Algernon Pharmaceuticals Inc. has announced a name change to Algernon Health Inc. Shares will begin trading under the new name and wit
Algernon Health completes rebrand to support Alzheimer's diagnostic strategy
08:46am, Wednesday, 15'th Oct 2025
Algernon Health (CSE:AGN, OTCQB:AGNPF) said it had completed its name change from Algernon Pharmaceuticals as the Canadian healthcare company pivots its focus toward the Alzheimer's disease diagnostic
Algernon Pharmaceuticals Completes Name Change to Algernon Health
07:00am, Wednesday, 15'th Oct 2025
VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare co
Algernon Health completes rebrand to support Alzheimer’s diagnostic strategy
04:43am, Wednesday, 15'th Oct 2025
Algernon Health (CSE:AGN, OTCQB:AGNPF) said it had completed its name change from Algernon Pharmaceuticals as the Canadian healthcare company pivots its...
PITTSBURGH , Oct. 7, 2025 /PRNewswire/ -- Catalyst MedTech today announced the launch of its new Connect program, an initiative that brings together collaborators seeking to advance patient care with
Algernon Health advances planned clinic rollout in scanner deal with Catalyst MedTech
07:46am, Thursday, 25'th Sep 2025
Algernon Health (CSE:AGN, OTCQB:AGNPF) told investors it has signed a C$4 million equipment order and financing agreement to acquire brain scanning systems that will be used in Algernon's planned n
VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
04:39pm, Friday, 19'th Sep 2025
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare
Algernon Pharmaceuticals changes name to Algernon Health
08:35am, Thursday, 04'th Sep 2025
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) announced it will change its name to Algernon Health as the company shifts its focus to the Alzheimer's disease (AD) diagnostic market. The company
